Cystic fibrosis (CF) is one of the most common genetic lung diseases worldwide. The production of sticky viscous mucus leads to enhanced bacterial colonization and infection, but yeasts and filamentous fungi are also found abundantly in the mucus of patients suffering from CF. The role of fungi in the airways of CF patients is still not understood completely. Furthermore, recent investigations have shown that the spectrum of fungi isolated from the airways of CF patients depends strongly on the methods used. In this study, different mycological culture methods were compared: culture with a native inoculum, culture with homogenization of CF sputum, and culture after homogenization and serial dilutions of CF sputum. Altogether, 934 sputum samples from 113 patients were examined from July 2009 through December 2011. A total of 1,744 fungal isolates was recovered; 20 different yeasts and 14 filamentous fungal species were identified. Candida albicans, C. dubliniensis, and C. parapsilosis were the most common species of yeast. For the filamentous fungi, Aspergillus fumigatus was the most common, followed by Scedosporium apiospermum/Pseudallescheria boydii group and A. terreus. Many fungal, species such as Exophiala dermatitidis, Rasamsonia (Geosmithia) argillacea, and others, were isolated only from homogenized sputum samples. The longitudinal data also show that fungal colonization of CF patients is quite stable, even when treated with itraconazole. In conclusion, we recommend homogenizing CF sputa with a mucolyticum, to prepare serial dilutions, and to use appropriate fungal culture media with added antibiotics.
Introduction
Cystic fibrosis (CF) is the most common hereditary lung disease in the Caucasian population [1] . CF is caused by mutations in the gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein, which is expressed in many epithelial and blood cells, resulting in 
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Downloaded from https://academic.oup.com/mmy/article-abstract/52/2/179/1026887 by guest on 14 January 2019 production of viscous bronchial secretions and consequently defective mucociliary clearance [2, 3] . The genetic defect leads to variable injury of the primary organs affected: upper and lower airways, exocrine pancreas, liver, and intestine [4] . In the lung, pathology is characterized by inflammation and airway obstruction, and recurrent or chronic infections with several bacterial species, such as Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia cepacia and Haemophilus influenzae [5] .
The airways of CF patients are often colonized by yeasts and filamentous fungi, which is facilitated by factors among others that include prolonged courses of antibiotic or corticosteroid treatment. Among the yeasts, Candida albicans is the predominant species, followed by C. parapsilosis or C. dubliniensis, depending on the study [6, 7] . Some centers have also reported an increasing number of isolates of the black yeast Exophiala dermatitidis [8] . Among the filamentous fungi, Aspergillus fumigatus has been reported to be isolated from 6-60% of CF patients' respiratory samples [9] , followed by Scedosporium/Pseudallescheria species and A. terreus [8] . Less common, but increasingly recognized to chronically colonize the airways are other species of Aspergillus, such as A. flavus and A. niger, and also Scedosporium prolificans. Recently, Geosmithia argillacea (now Rasamsonia argillacea) has been added to the list of frequently isolated moulds from CF patients [10] . However, the clinical significance of airway colonization with fungi remains a matter of debate [11] . About 6-25% of CF patients develop allergic bronchopulmonary aspergillosis (ABPA), which was shown to be a risk factor for increased decline of lung function and other severe complications [4, 12] . The role of fungal colonization of CF airways is also discussed in the context of inflammation and related pulmonary exacerbation of the disease [8] . Additionally, the relative risk of invasive aspergillosis after lung transplantation is higher for CF patients pre-transplant that are colonized with Aspergillus spp. than is the risk for CF patients without colonization [13] .
Fungal prevalence rates from studies in CF patients vary widely. In the USA, Nagano et al. [14] found an increase of fungal prevalence in CF sputum samples from 6-13% during the observation period from 1995-2005. In addition to patient-associated factors, this may be due to the lack of standardized procedures for mycological examination of CF sputa, and differences in the sensitivity of fungal culture methods used [15] . New molecular techniques have been shown to increase the sensitivity of fungal detection, making possible the identification of fungal species that were not found using conventional culture methods [3, 7] .
The aim of our study was to develop a reliable conventional culture technique to detect fungi in the airways of CF patients. We designed and optimized the laboratory protocol used in our routine microbiology laboratory for the detection of yeasts and filamentous fungi in CF patients. In a first step, we set out to compare the capacities of two different culture methods, a mycological culture with a native inoculum, and a mycological culture with homogenization of CF sputa with the mucolyticum Sputasol R (dithiothreitol 1.4%) (Oxoid Ltd, Basingstoke, Hampshire, UK), for determination of the diversity of fungi in CF sputum samples. Based on our first results, the latter pre-treatment protocol was further upgraded to include serial dilutions and a culture medium selective for Scedosporium/Pseudallescheria species, and evaluated its sensitivity for CF respiratory samples.
Materials and methods
Sputum samples from CF patients were analyzed in the mycology laboratory of the Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Austria. In a first step, between July 2009 and August 2010 detection of yeasts and filamentous fungi using two different microbiological techniques (protocols A and B) was compared.
Protocol A. Mycological culture with native inoculum
Undiluted sputum samples were split, one part was inoculated directly onto Candida chromogenic medium Candida ID2 (BioMérieux, Marcy-l'Etoile, France), and Sabouraud dextrose agar (SDA; Oxoid Ltd, Basingstoke, UK) supplemented with refobacin (gentamicin) (40 mg/l) and chloramphenicol (100 mg/l) to prevent or minimize bacterial growth.
Protocol B. Mycological culture with homogenization of CF sputum
The second part of the sputum samples from protocol A was immediately processed with Sputasol R (Oxoid) containing the sputum liquefying agent dithiothreitol in a weight ratio of 1:2. The sample was incubated at room temperature for 10-15 min, and vortex mixed. Subsequently, 100 μl each were plated onto Candida ID2 and SDA. In a second step, based on the results of protocol B, a modified culture technique was evaluated:
Protocol C. Mycological culture with homogenization and serial dilutions of CF sputum Sputum samples from CF patients were analyzed in the mycology laboratory between January 2010 and December 2011. The samples were processed as described above (protocol B), but the method was enhanced for quantification of fungal colony forming units (cfu) and for increase of the sensitivity of fungal detection by including serial dilutions. The latter were prepared from the suspension of origin in 10-fold dilution steps up to a 1000-fold dilution, 100 μl of each the liquefied and diluted suspensions were plated onto Candida ID2, SDA, and additionally onto SceSel+, a Scedosporium/Pseudallescheriaselective agar (Mykon, Innsbruck, Austria) [16] .
The agar plates from all three methods (protocols A, B, and C) were incubated at 35
• C and examined for fungal growth for 14 days. The number of colonies was counted from the dilution where colonies were in a countable range , and the cfu/g of sputum was calculated. Isolated colonies of yeasts were identified to species level by standard methods, including the use of the chromogenic medium, and MALDI-TOF MS Axima TM Assurance (Shimadzu, Japan).
For the latter, one colony of each isolate to be identified was directly spotted onto the FlexiMass MALDI target plate. For automatic measurement and identification, the SARAMIS TM (spectral archived microbial identification system) database application from bioMérieux was applied. Non-specific results were verified using DNA sequencing of the Internal Transcribed Spacer (ITS) region of the DNA coding for ribosomal RNA (rDNA), using primers ITS1 and ITS4 as described previously [17] . Filamentous fungi were identified to the species level by examining the culture morphology and by microscopy according to the Atlas of Clinical Fungi [18] . Isolates which could not be identified unambiguously with these methods were classified by sequencing the ITS region of rDNA.
Results
Between Table 1) . Using the mycological culture technique with homogenization of the CF sputum (protocol B), 249 fungal isolates were recovered from 178 of the 185 samples (96.2%). With protocol B, a higher cfu-count was found in 128 samples than in untreated samples. Compared to protocol A, 102 additional fungal isolates were cultured (Fig. 1 ). Of these, the most common was A. fumigatus (16 isolates), followed by C. albicans (8) , A. flavus (3), E. dermatitidis (2), A. terreus (2), C. parapsilosis (2) , and C. glabrata (1) .
With both methods, 12 fungal species were detected (7 yeasts, 5 filamentous fungi). The most common yeasts were C. albicans, C. dubliniensis and E. dermatitidis; A. fumigatus was the most prevalent filamentous fungus. Fungal species isolated using protocols A and B are compared in Table 1 Between January 2010 and December 2011, 749 sputum samples from 113 CF patients were analyzed with protocol C (mycological culture with homogenization and serial dilutions of CF sputa). A total of 1,338 fungal isolates was recovered from 692 of the 749 samples (92.4% fungus positive). Overall, 32 different fungal species were identified (18 yeasts and 14 filamentous fungi; Table 2 ). The most prevalent yeast isolated from CF patients was C. albicans in 439 (58.6%) sputa from 84 (74.3%) of the patients (Table 2 ). In a number of samples from 20 patients (17.7%), C. albicans was concurrently isolated with other species of Candida: with C. parapsilosis in 11 patients (9.7%), with C. glabrata in seven patients (6.2%), with C. dubliniensis in three patients (2.7%), and with both C. dubliniensis and C. glabrata in three patients (2.7%) (Supplementary 
Discussion
Fungal colonization of the airways in CF patients, facilitated by the frequent use of antibiotics and corticosteroids, along with the increase in life expectancy and lung transplantation, may lead to true respiratory infections with increasing frequency [7] . Although a variety of different yeasts and filamentous fungi was reported recovered from CF patients, the clinical significance in the course of the disease remains to be defined for several fungal species [9, 19] .
Differences in culture methods applied for CF sputum samples may account for widely varying prevalence rates of fungal species [15] . In a study from the UK, Pashley and co-workers demonstrated a significantly higher yield of A. fumigatus-positive cultures with a sputum processing method used on samples from asthma, chronic obstructive pulmonary disease (COPD), and CF compared to conventional methods [20] . A high-throughput pyrosequencing approach revealed a complex microbial community in which more than 60% of fungal species and genera were not detected by parallel culture techniques [3] . However, the number of sputum samples (8 from 4 adult CF patients) was rather small in this study. Furthermore, with molecular techniques it is not possible to differentiate between fungi colonizing airways and fungi that are only present as 'silent' propagules, which may not be able to grow at body temperature like some of the basidiomycetes listed by Delhaes and colleagues [3] , or fungi that are no longer alive.
Our results show that the mycological culture method with homogenization of CF sputum increases the sensitivity of fungal detection, compared to a mycological culture with a native inoculum, from 72.4-96.2% of samples. Conventional laboratory analysis without homogenization of the sputum samples failed to detect fungi in 45 patients (24%). Chemical homogenization with dithiothreitol facilitates liquefaction of highly viscous CF sputa and leads to homogenous distribution of pathogens in the clinical specimens. This effect was also reported for nasal secretions of patients suffering from chronic sinusitis, a material with a viscosity comparable to sputa from CF patients [21, 22] . With additional use of serial dilutions and media selective for fungal pathogens, which prevent overgrowth by other (fungal) microorganisms, a greater diversity of fungal species could be detected. In total, 32 fungal taxa were isolated, 20 (10 yeasts, 10 filamentous fungi) more compared to previous processing methods (Table 2 ). However, these data cannot be compared directly. Although they were obtained from the same patients, they were from a different (consecutive) set of samples. Weighing the sputum samples and the use of a defined sample volume allows the determination of quantitative plate counts (cfu/g), which may be a valuable tool for monitoring the course of colonization, which is not possible by simple plating of native samples.
The most prevalent yeast isolated from CF patients was C. albicans in 58.6% of sputa (74.3% of patients) ( Table 2 ). C. albicans was also the most frequently isolated yeast in other studies [6, 7] . When species of Candida were recovered from a patient, they were recovered from most of the subsequent samples from that patient, indicating maintenance of Candida species over time. In only three (of 84) patients the initial C. albicans colonization was no longer observed in latter samples; all three patients (# 40, 59, 113, Supplementary Table 2, to be found online at http://informahealthcare.com/doi/abs/10.3109/13693786. 2013.792438) received itraconazole treatment.
The clinical relevance of C. albicans is not clear, it is placed in category II (of IV) in the proposed classification for the clinical significance of yeasts and filamentous fungi in CF patients by Nagano et al.: 'Found relatively frequently in CF sputum. Clinical significance unknown in CF. These fungal organisms show a high association with CF sputum, although their clinical relevance has still to be clarified' [7] . However, C. albicans also was detected on the oral mucosa in up to 40% of healthy volunteers and therefore considered to be a commensal [23, 24] . On the other hand, Chotirmall and co-workers found that C. albicans colonization significantly predicted hospital-treated exacerbations (P = 0.004) [23] .
C. dubliniensis was found in 16.4% of respiratory samples (16.8% of patients) ( Table 2 ). This yeast has until recently only been reported from the oral cavity of HIV-infected persons. C. dubliniensis is morphologically very similar to C. albicans and often cannot be differentiated from the latter, even on some commercially available chromogenic media. In the literature the prevalence of C. dubliniensis in CF patients varies from 3.8-35%, it is the most frequently isolated yeast from respiratory samples of CF patients after C. albicans and in some studies after C. parapsilosis.
Third in the prevalence of yeasts in our study was the black yeast E. dermatitidis, with a frequency of 9.7% of samples (and 9.7% of patients) and thus was the most common non-Candida yeast (Table 2 ). This number corresponds with the occurrence of E. dermatitidis in CF patients reported by Horré et al., who found E. dermatitidis in 6.2% of their CF patients [25] . This species is characterized by slow growth on conventional mycological media and may often be overgrown by fast growing molds such as A. fumigatus. We found that the growth of E. dermatitidis needs at least 5-7 days in culture. Lebecque and co-workers proposed an incubation time of 14 days, which might be sufficient for most isolates of E. dermatitidis [26] . The clinical relevance of colonization of the airways of CF patients with E. dermatitidis is also not clear. Recently, it was shown in studies from Sweden and Belgium that colonization with this black yeast is strongly correlated with pancreatic insufficiency [26, 27] . However, E. dermatitidis is also involved in true respiratory infections in CF patients [28, 29] . The patients (11 in two years) with E. dermatitidis positive cultures were between 12 and 35 years of age (mean 20.5 years). This correlates well with the observations of Lebecque et al.; their E. dermatitidis-colonized patients were all over 12 years of age, with a mean of 22.6 years [26] . Colonization of our patients with E. dermatitidis was very persistent, with 71% (mean) and 100% (median), respectively, of positive samples. E. dermatitidis never occurred as the sole fungus, but was recovered mostly together with C. albicans (9; 82%) or A. fumigatus (8; 73%) (Supplementary Table 3 , to be found online at http://informahealthcare.com/doi/abs/10.3109/13693786.
2013.792438).
A. fumigatus was the most common filamentous fungus, with a sample prevalence of 53.9% in 78.8% of patients (Table 2 ). This is a higher prevalence than in other studies on the mycological content of CF respiratory samples. Mortensen [30] , whereas a rate of A. fumigatus-positive samples of 10.4% in a study from Turkey [6] and 5.2% from the UK (Northern Ireland) were rather low [7] .
In addition to A. fumigatus, two other species of Aspergillus were isolated frequently: A. terreus (3.2%; 8.0% patients) and A. flavus (2.7%; 7.1% patients) ( Table 2 ). Interestingly, A. terreus was isolated in more than one sample consecutively in six of nine patients, with a mean and median frequency of 36% and 25%, respectively (Supplementary Table 3 , to be found online at http://informahealthcare.com/doi/abs/10.3109/13693786. 2013.792438). A. flavus was repeatedly isolated from four of eight patients, with a mean and median frequency of 27% for both. The latter two species of Aspergillus may be important because of their resistance to amphotericin B by some isolates of A. terreus, and their still unknown role as in corpore producers of mycotoxins (aflatoxins) in the case of A. flavus, respectively.
Species of the S. apiospermum/P. boydii species group were isolated in 4.5% of sputum samples (10.6% patients) ( Table 2) . These species show a high continuous colonization rate, being isolated from eight of 12 patients (66.7%) in more than one consecutive sputum sample, with a mean and median frequency of 46% and 42%, respectively (Supplementary Tables 2 and 3 , to be found online at http://informahealthcare.com/doi/abs/10.3109/13693786. 2013.792438). The S. apiospermum/P. boydii species group has been ranked the second most common filamentous fungus associated with CF, with a prevalence rate of 0.5-11.9% [15, 19] . Other studies did not find S. apiospermum/ P. boydii species group in respiratory samples from CF patients [6] . This may be due to the slow growth of this fungus. On conventional mycological media such as SDA, malt extract agar, or commercially available chromogenic Candida agars this slow growing fungus is often overgrown by fast growing molds, such as A. fumigatus. In this study, homogenized and diluted sputum samples were plated on SceSel+ agar besides SDA and Candida ID2 agar, and incubated for up to 14 days. On SceSel+ agar fast growing filamentous fungi, such as A. fumigatus, are inhibited by addition of benomyl, while benomyl-tolerant zygomycetes are inhibited by addition of dichloran. Species identification below the level of S. apiospermum/ P. boydii species group was Downloaded from https://academic.oup.com/mmy/article-abstract/52/2/179/1026887 by guest on 14 January 2019 not performed with our samples, but will be done in the future.
Only recently the isolation of G. argillacea from CF patients was reported from France [10] and the UK [31] . We isolated this emerging pathogen from 18 respiratory samples (2.4%) from five patients (4.4%) ( Table 2) , always from more than two consecutive samples, with a mean and median frequency of 44% and 30%, respectively (Supplementary Table 3 , to be found online at http://informahealthcare.com/doi/abs/10.3109/13693786. 2013.792438). G. argillacea is an emerging medically relevant filamentous fungi because of its extreme thermotolerance (growth up to 50
• C), and its resistance against fluconazole and voriconazole [32] . Because of the morphological resemblance of G. argillacea to Penicillium and Paecilomyces species it is likely that it was and still is misdiagnosed, and therefore underestimated [33] . For some of our G. argillacea-colonized patients, we found the diagnosis of 'Penicillium sp.' in older reports. Based on molecular data, G. argillacea was recently renamed in Rasamsonia argillacea [34] and will be renamed again in Rasamsonia piperina in the near future (Houbraken J., CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands). Antifungal treatment was administered to some of the patients included in this study. The only antifungal used was itraconazole, mostly in a dosage of 2 × 2 capsules of 100 mg per day. In most instances, the spectrum of fungi isolated from patients treated with itraconazole did not differ from untreated patients, and patients with discontinuous treatment showed an unchanged colonization over the time period of two years. In only three patients (# 40, 59, 113, Supplementary Table 2, to be found online at http://informahealthcare.com/doi/abs/10.3109/13693786. 2013.792438) given itraconazole treatment did the colonization with C. albicans, and in one with C. parapsilosis, disappear (detailed data of treatment and fungal spectrum is shown in Supplementary Table 2 to be found online athttp://informahealthcare.com/doi/abs/10.3109/13693786. 2013.792438).
Whether this effect is based on high resistance of fungal isolates from patients suffering from CF, as discussed recently [35, 36] , was not subject of this study. The benefit of antifungal treatment in fungus-related exacerbation, such as ABPA, was reviewed by Müller and Seidler [37] . However, at present there are no randomized controlled trials to evaluate the use of antifungal therapies for the treatment of ABPA in CF patients [38] .
Nagano and colleagues used direct DNA extraction from CF sputum samples and fungal colonies, followed by PCR amplification of fungal rDNA and sequencing for identification of yeasts and filamentous fungi [7] . They demonstrated that a number of fungi might be missed by mycological culture methods alone. Since this method may also amplify fungi not able to colonize or infect the respiratory system, and because of the high cost of molecular analysis in routine laboratories, we recommend homogenization of CF sputa with dithiothreitol, serial dilution and subsequent use of appropriate fungal culture media with added antibiotics.
